Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
On November 27, 2019, Civeo Corporation (the "Company") was notified by the New
York Stock Exchange (the "NYSE") that the average closing price of the Company's
common shares, no par value (the "Common Shares"), over a prior 30 consecutive
trading day period was below $1.00 per share, which is the minimum average
closing price required to maintain listing on the NYSE under Section 802.01C of
the NYSE Listed Company Manual.
In general, a listed company has a period of six months following the receipt of
the notice to regain compliance. In order to regain compliance, on the last
trading day in any calendar month during the cure period, the Common Shares must
have (i) a closing price of at least $1.00 per share and (ii) an average closing
price of at least $1.00 per share over the 30 trading day period ending on the
last trading day of such month. If shareholder approval is required, the price
condition will be deemed cured if the price promptly exceeds $1.00 per share,
and the price remains above the level for at least the following 30 trading
days. If the Company is unable to regain compliance, the NYSE will initiate
procedures to suspend and delist the Common Shares.
As required by the NYSE, the Company has notified the NYSE of its intent to cure
the listing standard deficiency and restore its compliance with the NYSE
continued listing standards. If required to cure the deficiency and restore
compliance, the Company's Board of Directors intends to propose a reverse share
split for shareholder approval at the Company's annual meeting of shareholders
currently scheduled for May 2020.
The notice has no immediate impact on the listing of the Common Shares, which
will continue to be listed and traded on the NYSE during this period, subject to
the Company's compliance with the other listing requirements of the NYSE. The
Common Shares will continue to trade under the symbol "CVEO", but will have an
added designation of ".BC" to indicate the status of the Common Shares as "below
compliance".
If the Common Shares ultimately were to be delisted for any reason, it could
negatively impact the Company by (i) reducing the liquidity and market price of
the Company's Common Shares; (ii) reducing the number of investors willing to
hold or acquire the Common Shares, which could negatively impact the Company's
ability to raise equity financing; (iii) limiting the Company's ability to use a
registration statement to offer and sell freely tradable securities, thereby
preventing the Company from accessing the public capital markets; and (iv)
impairing the Company's ability to provide equity incentives to its employees.

--------------------------------------------------------------------------------




Item 7.01 Regulation FD Disclosure.
On December 4, 2019, the Company issued a press release with respect to the
receipt of the notice of noncompliance from the NYSE. A copy of the press
release is furnished as Exhibit 99.1 hereto and is incorporated by reference
herein.
The information contained in this Item 7.01 and the exhibit hereto shall not be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, and shall not be incorporated by reference into any filings
made by the Company under the Securities Act of 1933, as amended, or the
Exchange Act, except as may be expressly set forth by specific reference in such
filing.

--------------------------------------------------------------------------------




Item 9.01. Financial Statements and Exhibits.
(d)      Exhibits.



Exhibit No.    Description

99.1             Press release, dated December 4, 2019, issued by Civeo Corporation.

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses